- Drugs
- Friday, 15 May 2020
Sanofi says COVID-19 vaccine will be available globally at the same time
Sanofi will ensure that a potential vaccine against COVID-19, if approved, reaches all regions of the world at the same time, the chairman of the French drugmaker said on Thursday.
“There will be no particular advance given to any country,” Serge Weinberg told France 2 television.
“We are organised with several manufacturing units. Some of them are in the United States but even more of them are in Europe and France,” he said.
Sanofi operates 73 industrial locations in 32 countries. There is no vaccine approved yet against COVID-19, the illness caused by the new coronavirus.
The group’s chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world, after angering the French government earlier by saying the United States would get priority access.
Related Industry Updates
Antifungal Drugs Market is expected to reach US$ 13,997.4 Million in 2028
Jan 16, 2023
Bioidentical Hormones Market Growth Is Driven By The Increasing Demands of Various Therapies and Geographical Regions- 2027
Jan 04, 2021
Aquatic Veterinary Market is expected to reach US$ 1,934.33 million by 2030
Feb 19, 2024
North America Feminine Hygiene Products market size, share, Growth and Forecasts to 2027, Key Players are Procter & Gamble, Edgewell Personal Care, Bodywise (UK) Limited, Unicharm Corporation
Nov 30, 2020
CytoSorb® approved by the EU to remove rivaroxaban, a Factor Xa inhibitor
May 13, 2020
Middle East and Africa Botulinum Toxin Market is expected to reach US$ 453.55 million by 2030
Dec 06, 2023
Patient's genetic profile will now offer Personalize medicine
Sep 27, 2019
Follow us on
